৳ 1,300/unit
Pack: ৳ 1,300
৳ 1,300/unit
Pack: ৳ 1,300
At a glance
Tirzepatide is a GIP and GLP-1 receptor agonist used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Indications
- Type 2 diabetes mellitus (as an adjunct to diet and exercise)
Pharmacology
Tirzepatide activates GIP and GLP-1 receptors, enhancing glucose-dependent insulin secretion and reducing glucagon levels. It slows gastric emptying, reduces appetite, and promotes weight loss.
Dosage
Adult Dose (SC):
- Starting: 2.5 mg once weekly for 4 weeks
- Maintenance: 5 mg once weekly; increase by 2.5 mg every 4 weeks if needed; max 15 mg once weekly
Side effects
Common Side Effects:
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
- Dyspepsia
- Abdominal pain
Use in pregnancy
Use in Pregnancy: May be unsafe; use only if clearly needed; consult your doctor.
Pregnancy Category: D — always consult a doctor before taking during pregnancy.
Precautions & warnings
- Risk of thyroid C-cell tumors (MTC); contraindicated in personal/family history of MTC or MEN 2
- Do not use in type 1 diabetes or diabetic ketoacidosis
- Monitor for signs of pancreatitis
- Caution in history of diabetic retinopathy
- Monitor renal function with severe GI reactions
- Do not use during pregnancy
Overdose effects
Overdose may require supportive treatment; half-life approximately 5 days; monitor for symptoms.
Storage conditions
Store at 2-8°C in a refrigerator; do not freeze; protect from light; keep out of reach and sight of children.